Human-PD1 Discrepancies Raise Questions About Cancer Treatment Models
Scientists have found significant differences in how PD-1 works between humans and rodents, casting doubt on the use of common lab models for testing cancer therapies. Researchers at UC San Diego studied the evolutionary history of PD-1, a key player in cancer treatment, to understand its mechanism. They discovered that rodent PD-1 is significantly weaker … Read more